News

If the same marketing-authorization application is received in parallel by EMA and TGA, the two regulators have the possibility of scientific exchange to facilitate the evaluation of the

vitaPearl is a pearl-shaped softgel that is currently the smallest complete prescription prenatal multivitamin and is the first to contain Folmax, FePlus, and pur-DHA. TherapeuticsMD chief marketing officer

The McSwiggen patent estate broadly describes chemical modifications of RNAi therapeutics that the company believes are critical for achieving ‘drug-like’ properties in siRNA, the molecules that mediate RNAi.

According to the company, data submitted in the NDAs support the use of DCV+ASV in patients with genotype 1b hepatitis C (HCV). The company also seeks approval for

OMS721 targets mannan-binding lectin-associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system. In 2013, the company had announced that the FDA granted

According to the company, PALOMA-1 met its primary endpoint by prolonging progression-free survival (PFS) compared with letrozole alone in post-menopausal women with estrogen receptor positive (ER+), human epidermal

The recent reports have demonstrated PD-L1 to be up-regulated on the surface of tumor cells, implicating this protein as one of the factors that allows tumors to evade

The company has designed GENASSIST to make genome editing accessible for everyone. Horizon offers not just plasmids for CRISPR gene editing, but also custom guide RNA design and

With the three-year agreement, the company now enters into the growing Canadian OTC drug market, which was valued at more than $3.1bn in 2012. Jestaw has over 14